Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Schrauder, Michael G ^a,b   Strick, Reiner ^a,b   Schulz Wendtland, Rüdiger ^a   Strissel, Pamela L ^a,b   Kahmann, Laura ^a,b   Loehberg, Christian R ^a,b   Lux, Michael P ^a,b   Jud, Sebastian M ^a,b   Hartmann, Arndt ^a   Hein, Alexander ^a,b   Bayer, Christian M ^a,b   Bani, Mayada R ^a,b   Richter, Swetlana ^a,b   Adamietz, Boris R ^a   Wenkel, Evelyn ^a   Rauh, Claudia ^a,b   Beckmann, Matthias W ^a,b   Fasching, Peter A ^a,b,c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106B; MICRORNA 107; MICRORNA 1323; MICRORNA 1469; MICRORNA 1471; MICRORNA 182; MICRORNA 1915; MICRORNA 193A 3P; MICRORNA 202; MICRORNA 2355; MICRORNA 3186 3P; MICRORNA 335; MICRORNA 4257; MICRORNA 4306; MICRORNA 497; MICRORNA 516B; MICRORNA 526A; MICRORNA 564; MICRORNA 625; MICRORNA 718; MICRORNA 874; MICRORNA 922; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EARLY CANCER; FEMALE; HUMAN; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; UPREGULATION; VALIDATION PROCESS; BLOOD; BREAST TUMOR; DNA MICROARRAY; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BREAST NEOPLASMS; DOWN-REGULATION; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SUPPORT VECTOR MACHINES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84855374975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029770     Document Type: Article

References (80)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Lee RC, Feinbaum RL, Ambros V, (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
3. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
4. Ambros V, (2001) microRNAs: tiny regulators with great potential. Cell 107: 823-826.
5. Forman JJ, Legesse-Miller A, Coller HA, (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 105: 14879-14884.
6. Lytle JR, Yario TA, Steitz JA, (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc Natl Acad Sci U S A 104: 9667-9672.
7. Sun G, Rossi JJ, (2011) MicroRNAs and their potential involvement in HIV infection. Trends Pharmacol Sci.
8. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
9. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
10. Jiang J, Lee EJ, Gusev Y, Schmittgen TD, (2005) Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403.
11. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
12. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, et al. (2010) A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18: 303-315.
13. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
14. Negrini M, Nicoloso MS, Calin GA, (2009) MicroRNAs and cancer-new paradigms in molecular oncology. Curr Opin Cell Biol 21: 470-479.
15. Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, et al. (2010) miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med 16: 1134-1140.
16. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
17. Helland A, Anglesio MS, George J, Cowin PA, Johnstone CN, et al. (2011) Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One 6: e18064.
18. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
19. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
20. O'Day E, Lal A, (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12: 201.
21. Bockmeyer CL, Christgen M, Muller M, Fischer S, Ahrens P, et al. (2011) MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res Treat 130: 735-745.
22. Smeets A, Daemen A, Vanden Bempt I, Gevaert O, Claes B, et al. (2011) Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs. Breast Cancer Res Treat 129: 767-776.
23. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
24. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
25. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, et al. (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15: 5473-5477.
26. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
27. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, et al. (2011) MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8: 467-477.
28. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, et al. (2009) Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 4: e6229.
29. Kosaka N, Iguchi H, Ochiya T, (2010) Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092.
30. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
31. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008.
32. Wang F, Zheng Z, Guo J, Ding X, (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol.
33. Zhu W, Qin W, Atasoy U, Sauter ER, (2009) Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2: 89.
34. Roth C, Rack B, Muller V, Janni W, Pantel K, et al. (2010) Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12: R90.
35. Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, et al. (2009) MicroRNA expression profiling of male breast cancer. Breast Cancer Res 11: R58.
36. Kastl L, Brown I, Schofield AC, (2011) miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat [Epub ahead of print].
37. Rothe F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, et al. (2011) Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 6: e20980.
38. Di Stefano V, Zaccagnini G, Capogrossi MC, Martelli F, (2011) microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul Pharmacol.
39. Edge SB, Compton CC, (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471-1474.
40. Beekman JM, Reischl J, Henderson D, Bauer D, Ternes R, et al. (2009) Recovery of microarray-quality RNA from frozen EDTA blood samples. J Pharmacol Toxicol Methods 59: 44-49.
41. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
42. Vorwerk S, Ganter K, Cheng Y, Hoheisel J, Stahler PF, et al. (2008) Microfluidic-based enzymatic on-chip labeling of miRNAs. N Biotechnol 25: 142-149.
43. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M, (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1): S96-104.
44. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
45. Vapnik VN, (1999) An overview of statistical learning theory. IEEE Trans Neural Netw 10: 988-999.
46. Keller A, Ludwig N, Comtesse N, Hildebrandt A, Meese E, et al. (2006) A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors. BMC Bioinformatics 7: 539.
47. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N, (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76.
48. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
49. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, et al. (2009) miRNAs in lung cancer- studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353.
50. Sinclair N, Littenberg B, Geller B, Muss H, (2011) Accuracy of screening mammography in older women. AJR Am J Roentgenol 197: 1268-1273.
51. Miglioretti DL, Walker R, Weaver DL, Buist DS, Taplin SH, et al. (2011) Accuracy of screening mammography varies by week of menstrual cycle. Radiology 258: 372-379.
52. Britton P, Warwick J, Wallis MG, O'Keeffe S, Taylor K, et al. (2011) Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performance. Br J Radiol.
53. D'Orsi CJ, Newell MS, (2011) On the frontline of screening for breast cancer. Semin Oncol 38: 119-127.
54. Heneghan HM, Miller N, Kerin MJ, (2010) MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol.
55. Backes C, Meese E, Lenhof HP, Keller A, (2010) A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res 38: 4476-4486.
56. Roush S, Slack FJ, (2008) The let-7 family of microRNAs. Trends Cell Biol 18: 505-516.
57. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
58. Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, et al. (2011) Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat 127: 69-80.
59. Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, et al. (2011) Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 105: 296-303.
60. Peter ME, (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8: 843-852.
61. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8: R214.
62. Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, et al. (2009) MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res 11: R27.
63. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360.
64. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H, (2008) miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res 68: 5004-5008.
65. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, et al. (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A 105: 13021-13026.
66. Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, et al. (2010) Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer 103: 532-541.
67. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, et al. (2010) Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11: 50-54.
68. Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, et al. (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25: 226-231.
69. Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, et al. (2010) A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma. J Mol Diagn.
70. Wu Q, Lu Z, Li H, Lu J, Guo L, et al. (2011) Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol 2011: 597145.
71. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718.
72. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, et al. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6: 482-488.
73. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
74. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, et al. (2010) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5: e13735.
75. Leidinger P, Keller A, Borries A, Reichrath J, Rass K, et al. (2010) High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 10: 262.
76. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, et al. (2010) Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103: 693-700.
77. Heneghan HM, Miller N, Kerin MJ, (2011) Circulating microRNAs: promising breast cancer Biomarkers. Breast Cancer Res 13: 402.
78. Heneghan HM, Miller N, Kerin MJ, (2010) Systemic microRNAs: novel biomarkers for colorectal and other cancers? Gut 59: 1002-1004; author reply 004.
79. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ, (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15: 673-682.
80. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW, (2011) Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6: e20769.